pharma
-
The power of patient voice in clinical trial design
The increased patient-centric focus in drug development by the FDA is highly encouraging and expected to become more mainstream and legislated.
-
Artificial Intelligence, Pharma
Report: IBM is ending sales of Watson for Drug Discovery
IBM is stopping the development and sales of the product, which uses Watson AI to help pharmaceutical companies find new drugs, because it wasn’t yielding large enough financial returns, according to a STAT report.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
Why pharma is starting to think more like Amazon
As pharma continues to close the gap between the operational and analytical needs of their business, they can look to other industries for best practices.
-
Five innovation trends that will impact the healthcare industry in 2019
The behavioral health epidemic, artificial intelligence and more procedures being done in outpatient settings are some the key 2019 trends that will determine how decision makers purchase technology.
-
MedCity Influencers, BioPharma
Biopharma needs a new R&D, innovation model
Strategic partnerships are one way for biopharmaceutical companies to expand capabilities and offerings and proactively define their future versus having it defined for them.
-
What do CMIOs think of medication management initiatives?
A new survey found chief medical information officers believe medication management improvement initiatives have positively impacted patient safety, but factors like workflow variation and a lack of price transparency still compromise patients’ well-being.
-
Pharma is making inroads into digital health, albeit slowly
Panelists highlight Roche’s acquisition of Flatiron Health in February and use of AI/ML in drug development.
-
Roche acquires the rest of Foundation Medicine for $2.4B, supporting its precision medicine strategy
It’s the latest in a series of companies Roche has acquired to add services and technology to the Big Pharma’s drug development business, particularly in cancer treatment.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
-
Drugmakers increasingly target “baskets” of tumors based on mutations
A new report shows a steady growth in so-called “basket studies” in oncology, along with growing interest by the drug industry.